-+ 0.00%
-+ 0.00%
-+ 0.00%

REVIVA PHARMACEUTICALS: RECOVER-2 TRIAL PROJECTED TO COST ABOUT $60 MLN

Reuters·12/23/2025 13:06:55

Please log in to view news